PREventing Delayed Graft Function by Driving Immunosuppressive InduCtion Treatment (PREDICT-DGF): study protocol for a randomized controlled trial

BACKGROUND: In kidney transplantation, the use of Anti-Thymocyte Globulins (ATG) as induction therapy has been described as a possible treatment for reducing the prevalence of Delayed Graft Function (DGF). ATG possesses pharmaceutical proprieties that could help control the lesions caused by ischemi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Trials
Главные авторы: Chapal, Marion, Foucher, Yohann, Marguerite, Monique, Neau, Karine, Papuchon, Emmanuelle, Daguin, Pascal, Morélon, Emmanuel, Mourad, Georges, Cassuto, Elisabeth, Ladrière, Marc, Legendre, Christophe, Giral, Magali
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Study Protocol
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477597/
https://ncbi.nlm.nih.gov/pubmed/26099226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-0807-x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы